The Wall Street Journal: Pfizer asks FDA to authorize its 3-dose COVID vaccine for children under 5

Daily Trade

Pfizer Inc. and partner BioNTech SE asked U.S. health regulators to authorize three doses of their vaccine for children under 5 years.

The request Wednesday to the Food and Drug Administration comes after the companies said last month that three doses of the shot were 80% effective at preventing symptomatic COVID-19 and generated a robust immune response in children ages 6 months to 5 years old.

Articles You May Like

ZM (Zoom) – Bullish Diagonal Spread [Options Strategy]
Nvidia (NVDA) Stock Earnings: What Should Investors Watch For?
Bloomin’ Brands (BLMN) and Lovesac (LOVE): 4/6/2023 Bull & Bear
New Top 5 Sectors | Stock Market Analysis | (RTN) (OSK) (HXL) (STP) (SWX)
35 TIP: How Currencies Work – FOREX Investing